PCCM fellow @MayoClinic @MayoPCCM IM trained @BMCimRES | Interests include but not limited to #POCUS, meded and autoimmunity #RheumCrit 🩺⚕️

Rochester, MN
Joined June 2013
Jose A. Meade, MD retweeted
Cómo te voy a extrañar, Pancho querido. Tantos años. Siempre un profesional. Sólo nos quedó pendiente tu fiesta de cumple. Me vas a hacer falta todas las mañanas en Excélsior. bit.ly/3VuyvnT
11
63
1
698
46,616
Jose A. Meade, MD retweeted
🕊️ Todos los que formamos parte de #GrupoImagen lamentamos profundamente el fallecimiento de nuestro querido colaborador Francisco Garfias. Nos unimos a la pena que embarga a sus familiares y seres queridos, a quienes deseamos fortaleza y pronta resignación ante esta pérdida. Descanse en paz.
19
62
3,555
Jose A. Meade, MD retweeted
Original Article: Vasopressors or Fluids in Early Septic Shock (ARISE FLUIDS trial) nej.md/3PVdwIp Editorial: More Than One Way to Save a Life in Septic Shock nej.md/4j1pPio #EmergencyMedicine #CriticalCare
6
82
3
302
37,342
Jose A. Meade, MD retweeted
Despedimos a Francisco Garfias, periodista que durante casi cinco décadas informó con mirada crítica sobre la vida pública de México. Extrañaremos al reportero comprometido y al amigo entrañable. Descanse en paz. Un abrazo solidario a su familia y amigos.
278
128
21
384
17,836
Jose A. Meade, MD retweeted
Conocí a Francisco Garfias en 1997 cuando coincidimos en la Cámara de Diputados, él siempre periodista y muy buena persona. Hasta la vista Pancho !! Mis condolencias a familiares y amigos.
8
26
1
219
47,952
Jose A. Meade, MD retweeted
Murió el periodista Pancho Garfias. Mi pésame a sus familiares, amigos y compañeros. Descanse en paz. Las noticias en lopezdoriga.com
5
24
154
14,502
Jose A. Meade, MD retweeted
Academic docs doing disparities research? I can think of many better ways to help with healthcare disparities. Try practicing in Nevada or really any community with not enough healthcare. Boston doesn’t need anymore docs.
14
16
1
238
23,836
Se fue un grande y muy querido, Tío Pancho Garfias, descansé en paz. Extrañaré tus pláticas siempre con humor e intelecto.
Con pena me enteré que murió Francisco Garfias (@panchogarfias). Con él se va uno de los periodistas que mejor entendió al Congreso mexicano: sus reglas, sus pasillos y sus personajes. Entre 1997 y 2018 el Congreso ocupó el centro de gravedad de la política nacional. Ningún presidente tuvo mayoría propia. El presupuesto, la ley de ingresos y cualquier reforma tenían que negociarse en San Lázaro y en el Senado. Los paquetes económicos dejaron de aprobarse tal como llegaban. Buena parte de mi trayectoria pública transcurrió en esos años, que tuvieron en Garfias a uno de sus mejores cronistas: informado, puntual, con fuentes en todas las bancadas. Su oficio no dependía de la coyuntura. "Arsenal" fue lectura obligada antes, durante y después, hasta el final. Fue amigo de mi papá y mío. Descanse en paz. Ofrezco un abrazo y mis oraciones a su familia y a sus colegas.
2
304
Jose A. Meade, MD retweeted
We've spent decades staring at the arterial line. Turns out the veins have feelings too, and a congested patient can look "fine" on the monitor while their organs struggle. 🎩 tip to the authors. eddyjoemd.com/foamed
42
123
5,743
Jose A. Meade, MD retweeted
@MayoPCCM 2026 Distinguished CHEST Educators. The DCE is an annual designation from @accpchest recognizing the top 3% CHEST faculty for sustained excellence in designing, delivering and leading PCCM education. Congratulations to our faculty! #meded
8
13
922
Jose A. Meade, MD retweeted
1/ How common is antiphospholipid syndrome (APS)? The answer is more complicated than it seems. In our new Nature Reviews Rheumatology review, we examine why defining the true epidemiologic burden of APS remains challenging. Full paper here👉: rdcu.be/M2Loes1Gqtia
2
18
53
3,182
Jose A. Meade, MD retweeted
A tribute to Bob Kyle shown today at the Annual Meeting of the International Myeloma Society. #IMS26 #IMS2026 A role model and inspiration to many. Bookmark! We will miss him. @Myeloma_Society @IMFmyeloma @Myeloma_mSMART
1
28
2
106
9,089
Jose A. Meade, MD retweeted
Personalized fluids for everyone because they "may reduce mortality." I appreciate this article because it confirms my biases. Also, ignore the small sample sizes and the acknowledged limitations. 🎩 tip to the authors. eddyjoemd.com/foamed
14
1
37
2,296
❤️Echocardiography in shock: stop asking only “What is the EF?” In undifferentiated shock, echocardiography is most useful when it answers physiological questions, not when it simply describes cardiac anatomy. Colebourn and Fisher propose a pragmatic 5 question framework for approaching the shocked patient: 1. What are the stroke volume and cardiac output? Start with flow. Importantly, cardiac index is not a binary marker of shock. A patient may maintain cardiac output through tachycardia despite a low stroke volume, while another may have low output because bradycardia prevents compensation. SVI, CI, heart rate and rhythm therefore need to be interpreted together. 2. If output is abnormal, why? LV failure? RV failure? Low preload? Valve disease? Mechanical complication? Obstruction? And do not forget dynamic LVOTO. Critical illness can combine low LV volume with hypercontractility, and escalating vasoactive support without recognising LVOTO may paradoxically worsen shock. This is also where LVEF can mislead us. A “normal” EF does not guarantee adequate forward flow. EF depends on LV volume and afterload and does not distinguish forward from regurgitant stroke volume. Vasoplegia may even make LV systolic function appear reassuring until vascular tone is restored. 3. Is left atrial pressure elevated? E/e′ >14 may support elevated LAP in general ICU populations, but performs less reliably in cardiogenic shock and should not be interpreted alone. A normal LA size does not exclude an acute rise in LAP. 4. Are pulmonary pressure and PVR elevated? Now the assessment moves to the RV pulmonary circulation interaction, where pressure, afterload and RV adaptation matter. 5. How is the situation evolving? Perhaps the most important question. The echo we see is not the patient's fixed cardiovascular phenotype. It is the heart under the current preload, afterload, vasoactive therapy and ventilatory conditions. Noradrenaline can increase BP while decreasing SV in one patient, yet increase both BP and SV in another. This is why critical care echocardiography should increasingly be thought of as: Flow → Mechanism → Filling pressures → RV pulmonary circulation → Response over time Not a photograph. A dynamic physiological assessment. This paper represents pragmatic expert guidance rather than a validated diagnostic algorithm. Reference📚 Colebourn C, Fisher R. A structured 5-question approach for echocardiographic evaluation of undifferentiated shock. Echo Res Pract. 2026;13:30. doi.org/10.1186/s44156-026-0… #CriticalCare #Echocardiography #POCUS #Shock #Hemodynamics #Cardiology #IntensiveCare
2
92
280
12,843
Jose A. Meade, MD retweeted
How much (approximately) do the vasoactive medications we use cost? 🎩 tip to the authors including @SXC71 @pwierusz and Ortoleva who I had the pleasure of meeting yesterday at #ELSO2026 eddyjoemd.com/foamed
2
11
27
2,342
Jose A. Meade, MD retweeted
Since esophageal pressure monitoring and electrical impedance tomography are so frequently discussed in the literature, as a community hospital intensivist, I have to ask: do you all routinely use these in academic centers? 🎩 tip to the authors. eddyjoemd.com/foamed
9
36
130
6,848
Jose A. Meade, MD retweeted
Our paper is out! @ThinkingCC @khaycock2 @EMNerd_ We revisit critical closing pressure (CCP) and show why ~50 years of confusion arose — and why CCP has been repeatedly misused as a perfusion pressure, an autoregulatory variable, and a “waterfall” you can manipulate. CCP isn’t niche. Used correctly, it explains haemodynamic incoherence and guides personalised shock care. mdpi.com/2075-4426/16/2/78
10
49
4
119
17,303